Avalyn Pharma Inc. (AVLN) — Stock Score Summary

Avalyn Pharma Inc. (AVLN) has a MoatMap StockRank of 9/100 based on Quality (28/100), Value (36/100), and Momentum (26/100) factor scores. The current signal is STRONG SELL. Avalyn Pharma is a clinical-stage biopharmaceutical company. Without commercialized products or positive owner earnings, it fails our Buffett and Terry Smith quality filters.

Avalyn Pharma Inc. is a clinical-stage biotechnology company focused on developing inhaled therapies for the treatment of interstitial lung diseases, including idiopathic pulmonary fibrosis. The company's competitive advantage lies in its proprietary aerosolized formulations designed to deliver therapeutic agents directly to the lungs, minimizing systemic side effects. As a niche player in pulmonary medicine, Avalyn aims to improve patient outcomes by optimizing drug delivery for severe respiratory conditions.

Key Financial Metrics

Price$28.67
Market Cap$1.3B
P/E (Forward)-14.21
Price/Book-2.67
Return on Equity-68.3%
Return on Invested Capital-67.7%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-51M

Avalyn Pharma Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Avalyn Pharma Inc.’s (AVLN) StockRank?
MoatMap’s StockRank for Avalyn Pharma Inc. (AVLN) is 9/100, with a Strong Sell signal. It is a composite of Quality (28), Value (36), and Momentum (26) factor ranks across MoatMap’s 19,000+ stock universe.
Does Avalyn Pharma Inc. have an economic moat?
Avalyn Pharma Inc. (AVLN) has a Quality factor score of 28/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Avalyn Pharma Inc. a buy, hold, or sell?
MoatMap’s current signal for Avalyn Pharma Inc. (AVLN) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Avalyn Pharma Inc. in?
Avalyn Pharma Inc. (AVLN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAVLN deep dive reportAI ChampionsHow we score stocksSense-check another stock